SCHEMBL18436371

SCHEMBL18436371

COC(=O)N1[C@H](C)CN(c2ccccc2)C[C@H]1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.49
CYP2C19 P33261 4/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
MAPK1 P28482 1/20 0.49
USP2 O75604 3/20 0.48
HSD17B10 Q99714 3/20 0.48
CYP1A2 P05177 3/20 0.43
TSHR P16473 2/20 0.43
CYP2C9 P11712 2/20 0.43
FAAH O00519 2/20 0.42
NOTUM Q6P988 1/20 0.41
ALDH1A1 P00352 3/20 0.41
HTR2C P28335 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
GRM5 P41594 1/20 0.40
GPR119 Q8TDV5 1/20 0.40
ABCB1 P08183 1/20 0.40
SIGMAR1 Q99720 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18436080 1.00 CYP3A4 (0.49) CYP3A4CYP2C19MEN1KMT2AMAPK1
SCHEMBL21336928 0.86 CYP3A4 (0.41) CYP3A4CYP2C19MEN1KMT2AMAPK1
SCHEMBL18436107 0.86 L3MBTL1 (0.41) MEN1KMT2AMAPK1TSHRALDH1A1
SCHEMBL18436332 0.86 L3MBTL1 (0.41) MEN1KMT2AMAPK1TSHRALDH1A1
SCHEMBL19012516 0.86 L3MBTL1 (0.41) MEN1KMT2AMAPK1TSHRALDH1A1
SCHEMBL21336929 0.84 HTR2C (0.49) TSHRFAAHALDH1A1HTR2CMAPT
SCHEMBL21336572 0.84 L3MBTL1 (0.40) CYP3A4CYP2C19MEN1KMT2AMAPK1
SCHEMBL18436501 0.84 FAAH (0.38) CYP3A4CYP2C19MEN1KMT2AMAPK1
SCHEMBL21336726 0.83 GPR119 (0.56) FAAHALDH1A1MAPTGPR119ABCB1
SCHEMBL18436059 0.83 NR1H2 (0.42) CYP3A4CYP2C19MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124482-A1 QUINOLINE DERIVATIVES AS SMO INHIBITORS GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2017-02-01 EP disclosed